These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31774531)

  • 21. Patterns and predictors of change in outcome measures in clinical trials in scleroderma: an individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosis.
    Merkel PA; Silliman NP; Clements PJ; Denton CP; Furst DE; Mayes MD; Pope JE; Polisson RP; Streisand JB; Seibold JR;
    Arthritis Rheum; 2012 Oct; 64(10):3420-9. PubMed ID: 22328195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapamycin versus methotrexate in early diffuse systemic sclerosis: results from a randomized, single-blind pilot study.
    Su TI; Khanna D; Furst DE; Danovitch G; Burger C; Maranian P; Clements PJ
    Arthritis Rheum; 2009 Dec; 60(12):3821-30. PubMed ID: 19950289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reliability and Validity of the Tender and Swollen Joint Counts and the Modified Rodnan Skin Score in Early Diffuse Cutaneous Systemic Sclerosis: Analysis from the Prospective Registry of Early Systemic Sclerosis Cohort.
    Gordon JK; Girish G; Berrocal VJ; Zhang M; Hatzis C; Assassi S; Bernstein EJ; Domsic RT; Hant FN; Hinchcliff M; Schiopu E; Steen VD; Frech TM; Khanna D
    J Rheumatol; 2017 Jun; 44(6):791-794. PubMed ID: 28298560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
    Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP
    Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database.
    Lescoat A; Huang S; Carreira PE; Siegert E; de Vries-Bouwstra J; Distler JHW; Smith V; Del Galdo F; Anic B; Damjanov N; Rednic S; Ribi C; Bancel DF; Hoffmann-Vold AM; Gabrielli A; Distler O; Khanna D; Allanore Y;
    JAMA Dermatol; 2023 Aug; 159(8):837-847. PubMed ID: 37378994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunosuppressive treatment in diffuse cutaneous systemic sclerosis is associated with an improved composite response index (CRISS).
    Zheng B; Hudson M; Wang M; Baron M;
    Arthritis Res Ther; 2020 Jun; 22(1):132. PubMed ID: 32503616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of sensitivity to change of the European Scleroderma Study Group activity index.
    Melsens K; De Keyser F; Decuman S; Brusselle G; De Pauw M; Deschepper E; De Wilde K; Elewaut D; Piette Y; Vandecasteele E; Smith V
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):148-151. PubMed ID: 27463733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group.
    Jordan S; Distler JH; Maurer B; Huscher D; van Laar JM; Allanore Y; Distler O;
    Ann Rheum Dis; 2015 Jun; 74(6):1188-94. PubMed ID: 24442885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Observational study of treatment outcome in early diffuse cutaneous systemic sclerosis.
    Herrick AL; Lunt M; Whidby N; Ennis H; Silman A; McHugh N; Denton CP
    J Rheumatol; 2010 Jan; 37(1):116-24. PubMed ID: 19955050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of clinical features in early-onset severe systemic sclerosis: An analysis from a multicenter prospective observational Japanese cohort.
    Uesugi-Uchida S; Fujimoto M; Asano Y; Endo H; Goto D; Jinnin M; Kawaguchi Y; Tanaka S; Tokunaga T; Makino K; Matsushita T; Motegi SI; Yoshizaki A; Sato S; Hasegawa M
    J Dermatol; 2024 Oct; 51(10):1290-1297. PubMed ID: 39235167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective observational study of mycophenolate mofetil treatment in progressive diffuse cutaneous systemic sclerosis of recent onset.
    Mendoza FA; Nagle SJ; Lee JB; Jimenez SA
    J Rheumatol; 2012 Jun; 39(6):1241-7. PubMed ID: 22467932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study.
    Herrick AL; Peytrignet S; Lunt M; Pan X; Hesselstrand R; Mouthon L; Silman AJ; Dinsdale G; Brown E; Czirják L; Distler JHW; Distler O; Fligelstone K; Gregory WJ; Ochiel R; Vonk MC; Ancuţa C; Ong VH; Farge D; Hudson M; Matucci-Cerinic M; Balbir-Gurman A; Midtvedt Ø; Jobanputra P; Jordan AC; Stevens W; Moinzadeh P; Hall FC; Agard C; Anderson ME; Diot E; Madhok R; Akil M; Buch MH; Chung L; Damjanov NS; Gunawardena H; Lanyon P; Ahmad Y; Chakravarty K; Jacobsen S; MacGregor AJ; McHugh N; Müller-Ladner U; Riemekasten G; Becker M; Roddy J; Carreira PE; Fauchais AL; Hachulla E; Hamilton J; İnanç M; McLaren JS; van Laar JM; Pathare S; Proudman SM; Rudin A; Sahhar J; Coppere B; Serratrice C; Sheeran T; Veale DJ; Grange C; Trad GS; Denton CP
    Ann Rheum Dis; 2018 Apr; 77(4):563-570. PubMed ID: 29306872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical worsening following discontinuation of tocilizumab in diffuse cutaneous systemic sclerosis: a single-centre experience in Japan.
    Isomura Y; Shirai Y; Kuwana M
    Rheumatology (Oxford); 2022 Nov; 61(11):4491-4496. PubMed ID: 35258561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A preliminary study of acoustic radiation force impulse quantification for the assessment of skin in diffuse cutaneous systemic sclerosis.
    Hou Y; Zhu QL; Liu H; Jiang YX; Wang L; Xu D; Li MT; Zeng XF; Zhang FC
    J Rheumatol; 2015 Mar; 42(3):449-55. PubMed ID: 25593239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twelve-month azathioprine as maintenance therapy in early diffuse systemic sclerosis patients treated for 1-year with low dose cyclophosphamide pulse therapy.
    Paone C; Chiarolanza I; Cuomo G; Ruocco L; Vettori S; Menegozzo M; La Montagna G; Valentini G
    Clin Exp Rheumatol; 2007; 25(4):613-6. PubMed ID: 17888219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of micronutrient antioxidants (alpha-tocopherol and ascorbic acid) on skin thickening and lung function in patients with early diffuse systemic sclerosis.
    Ostojic P; Damjanov N
    Rheumatol Int; 2011 Aug; 31(8):1051-4. PubMed ID: 20309694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.
    Khanna D; Spino C; Johnson S; Chung L; Whitfield ML; Denton CP; Berrocal V; Franks J; Mehta B; Molitor J; Steen VD; Lafyatis R; Simms RW; Gill A; Kafaja S; Frech TM; Hsu V; Domsic RT; Pope JE; Gordon JK; Mayes MD; Schiopu E; Young A; Sandorfi N; Park J; Hant FN; Bernstein EJ; Chatterjee S; Castelino FV; Ajam A; Wang Y; Wood T; Allanore Y; Matucci-Cerinic M; Distler O; Singer O; Bush E; Fox DA; Furst DE
    Arthritis Rheumatol; 2020 Jan; 72(1):125-136. PubMed ID: 31342624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohort.
    Jaafar S; Lescoat A; Huang S; Gordon J; Hinchcliff M; Shah AA; Assassi S; Domsic R; Bernstein EJ; Steen V; Elliott S; Hant F; Castelino FV; Shanmugam VK; Correia C; Varga J; Nagaraja V; Roofeh D; Frech T; Khanna D
    Arthritis Res Ther; 2021 Jun; 23(1):170. PubMed ID: 34127049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The correlation between durometer score and modified Rodnan skin score in systemic sclerosis.
    Moon KW; Song R; Kim JH; Lee EY; Lee EB; Song YW
    Rheumatol Int; 2012 Aug; 32(8):2465-70. PubMed ID: 21769489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of EUSTAR standardized training on accuracy of modified Rodnan skin score in patients with systemic sclerosis.
    Park JW; Ahn GY; Kim JW; Park ES; Kang JH; Chang SH; Choi IA; Yoo SJ; Park JK; Shin K; Park YB; Jun JB; Czirják L; Allanore Y; Matucci-Cerinic M; Lee EB
    Int J Rheum Dis; 2019 Jan; 22(1):96-102. PubMed ID: 30398033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.